Aberdeen Group
QNRX

Aberdeen Group’s Quoin Pharmaceuticals QNRX Stock Holding History

Aberdeen Group’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Hold
75,000
– – ﹤0.01% 907
2026
Q1 		$495K Hold
75,000
– – ﹤0.01% 883
2025
Q4 		$1.08M Buy
+75,000
New +$1.02M ﹤0.01% 826

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Aberdeen Group's QNRX Position: Q2 2026 in Review

Aberdeen Group held its Quoin Pharmaceuticals (QNRX) position steady in Q2 2026 at 75,000 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #907.

Aberdeen Group first reported a position in QNRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.08M in Q4 2025. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • Aberdeen Group held 75,000 shares of Quoin Pharmaceuticals worth $363K as of Q2 2026.
  • Aberdeen Group left its Quoin Pharmaceuticals share count unchanged in Q2 2026.
  • Quoin Pharmaceuticals made up ﹤0.01% of Aberdeen Group's portfolio in Q2 2026, its #907 holding.
  • Aberdeen Group first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Aberdeen Group's Quoin Pharmaceuticals position peaked at $1.08M in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.